NovoCure Earnings
NASDAQ: NVCRHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$-0.21
NovoCure earnings summary
NovoCure is scheduled to report Sep/2026 earnings on Oct 29, 2026 before the market opens, with analysts expecting EPS of $-0.21. In its most recent report on Jul 23, 2026 (Q2 2026), NVCR posted EPS of $-0.13. Revenue for the quarter was $183.6 million.
Across the last 16 reports, NVCR shares moved an average of 7.4% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
NVCR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 23, 2026 | — | $-0.13 | — | -15.9% |
| Apr 30, 2026 | — | $-0.62 | — | +7.6% |
| Jan 12, 2026 | — | $-0.22 | — | -1.4% |
| Oct 30, 2025 | — | $-0.33 | — | -14.8% |
| Jul 24, 2025 | — | $-0.36 | — | -6.0% |
| Apr 24, 2025 | — | $-0.31 | — | -1.9% |
| Jan 13, 2025 | — | $-0.61 | — | +0.6% |
| Oct 30, 2024 | — | $-0.28 | — | +7.8% |
| Jul 25, 2024 | — | $-0.31 | — | +8.9% |
| May 2, 2024 | — | $-0.36 | — | +11.4% |
| Feb 22, 2024 | — | $-0.45 | — | +6.8% |
| Oct 26, 2023 | — | $-0.46 | — | +9.0% |
| Jul 27, 2023 | — | $-0.54 | — | -14.3% |
| May 4, 2023 | — | $-0.50 | — | +9.9% |
| Feb 23, 2023 | — | $-0.36 | — | +1.5% |
| Oct 27, 2022 | — | $-0.25 | — | +0.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.